May 2011

THE FAIR PRICING COALITION EXPRESSES DISMAY AT THE PRICE OF MERCK’S NEWLY APPROVED HEPATITIS C DRUG

May 17, 2011—On May 13, 2011, the FDA approved Merck’s Victrelis (boceprevir), the first new drug for the treatment of hepatitis C virus (HCV) infection to come to market in almost ten years. The United States Department of Health and Human Services estimates that there are between 2.7 to 3.9 million people in the United […]

THE FAIR PRICING COALITION EXPRESSES DISMAY AT THE PRICE OF MERCK’S NEWLY APPROVED HEPATITIS C DRUG Read More »

Chicago: “Promising Advances in HIV Cure and Healthy Aging Research” on Tuesday, May 31 from 6:30-8 pm

I hope to see anyone living in Chicago in this lecture! Read the last two paragraphs for details. When AIDS service providers talk about condom campaigns and safer sex, most people assume they’re not talking to Chicago seniors. But if experts have it right, they need to start.HIV infection rates among Illinois seniors are climbing,

Chicago: “Promising Advances in HIV Cure and Healthy Aging Research” on Tuesday, May 31 from 6:30-8 pm Read More »

Men’s health lecture in New York on May 24

For those who could not attend this lecture, here are a few available online: Video Lectures Lecture Handouts To stay updated, register on Nelson Vergel’s new men’s health site that covers information on testosterone replacement, erectile function, sex drive, HCG, anastrozole, nutrition, supplements, exercise, and much more https://www.excelmale.com/forum.php

Men’s health lecture in New York on May 24 Read More »

HIV and nanotechnology: Workshop report i-base.info

Given the potential advantage of providing reduced toxicity, more durable formulations with improved pharmacokinetics (ie targeting macrophages to increase concentrations in lymph tissue and dramatically extending half-life and dosing intervals) and at a reduced cost makes it frustrating that so far none of these formulations has yet progressed to human studies. A must read! https://i-base.info/htb/14934

HIV and nanotechnology: Workshop report i-base.info Read More »

Recent Health Related Answers by Nelson Vergel at TheBody.com

Joint problems May 10, 2011 Difference between Creatine and Creatinine May 10, 2011 VIRAL LOAD NOT DETECTED May 10, 2011 Recently diagnosed, supplements and multivitamins May 10, 2011 GANAR PESO May 10, 2011 Nutrition Advice to Lose Weight/Build Muscle May 10, 2011 Long flight to visit someone with low CD4 – precautions to protect them

Recent Health Related Answers by Nelson Vergel at TheBody.com Read More »

Two part video of Per Larson’s lecture on financial health and HIV

These are two videos about Per Larson’s lecture in Houston a few weeks ago. Here are part one and part two.  This is raw footage without editing. https://dl.dropbox.com/u/28185665/100_0001.MOV http://dl.dropbox.com/u/28185665/10010001.MOV More about Per Larson: https://outsmartmagazine.com/2011/03/will-you-outlive-your-money/

Two part video of Per Larson’s lecture on financial health and HIV Read More »

Is There a Future for HIV-Infected Patients in “Deep Salvage”?

Print this page    •   Back to Web version of article By Nelson Vergel, B.S.Ch.E., M.B.A. May 3, 2011 “Only patients who do not take their medications as prescribed have multidrug resistance.” “Deep salvage patients no longer exist. The ones in that situation are already dead or have responded to the latest HIV antiretrovirals.” “Even if we give

Is There a Future for HIV-Infected Patients in “Deep Salvage”? Read More »